Head J R, MacDonald P C, Casey M L
Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas 75235-9051.
J Clin Endocrinol Metab. 1993 Mar;76(3):769-76. doi: 10.1210/jcem.76.3.8445036.
Previously, we found that membrane metalloendopeptidase (MMEP; enkephalinase) is present in human endometrium where it may inactivate certain bioactive peptides such as endothelin. The specific activity of MMEP in endometrium is correlated positively with the level of plasma progesterone. In the present study, we determined the cellular distribution of MMEP immunoreactivity (IR) in samples of endometrium from 31 ovulatory women at different phases of the menstrual cycle and from 5 postmenopausal women. At all times, MMEP-IR was localized in the endometrial stromal cells and was absent from myometrium, epithelia, and vessels. The presence of the enzyme on the stromal cell plasma membrane was demonstrated by immunostaining of freshly isolated endometrial stromal cells. During the endometrial cycle, there were dramatic changes in MMEP-IR in the zona functionalis: In the proliferative phase when plasma progesterone levels were low, MMEP-IR was weak; but after ovulation, during the early and midsecretory phases, when progesterone levels were increasing or high, MMEP-IR was strong. During the late secretory phase, in the stromal areas that were decidualized, contiguous with spiral arterioles and beneath the surface epithelium, most of the MMEP-IR was lost, whereas MMEP in the other stromal areas remained strong. In the premenstrual phase, there was a more generalized decline in MMEP-IR in the stromal cells. MMEP-IR in the zona basalis was weak to moderate and was relatively unchanged during the ovarian cycle; the findings in postmenopausal tissues were similar to those of proliferative phase tissues. These results are consistent with the previous findings of increased MMEP mRNA, protein, and activity in endometrial tissue of midsecretory phase and in cultured endometrial stromal cells in response to progestin. Furthermore, in this study, we demonstrate that in the late secretory phase in decidualizing stroma, MMEP-IR is decreased considerably compared with midsecretory stromal cells. These changes in MMEP-IR are consistent with the possibility that endothelin, also produced in endometrium, is spared inactivation in the premenstrual phase and may act on the spiral arterioles. These findings are supportive of a role for MMEP in paracrine interactions affecting vascular homeostasis in the endometrium.
此前,我们发现膜金属内肽酶(MMEP;脑啡肽酶)存在于人类子宫内膜中,它可能使某些生物活性肽如内皮素失活。子宫内膜中MMEP的比活性与血浆孕酮水平呈正相关。在本研究中,我们测定了31名处于月经周期不同阶段的排卵女性和5名绝经后女性子宫内膜样本中MMEP免疫反应性(IR)的细胞分布。在所有时期,MMEP-IR均定位于子宫内膜基质细胞,而子宫肌层、上皮和血管中不存在。通过对新鲜分离的子宫内膜基质细胞进行免疫染色,证实了该酶存在于基质细胞质膜上。在子宫内膜周期中,功能层的MMEP-IR有显著变化:在增殖期,血浆孕酮水平较低时,MMEP-IR较弱;但排卵后,在分泌期早期和中期,孕酮水平升高或处于高位时,MMEP-IR较强。在分泌晚期,在蜕膜化的基质区域,与螺旋小动脉相邻且位于表面上皮下方,大部分MMEP-IR消失,而其他基质区域的MMEP仍较强。在经前期,基质细胞中的MMEP-IR有更普遍的下降。基底层的MMEP-IR较弱至中等,在卵巢周期中相对不变;绝经后组织中的发现与增殖期组织相似。这些结果与先前关于分泌中期子宫内膜组织和培养的子宫内膜基质细胞中MMEP mRNA、蛋白质和活性因孕激素而增加的发现一致。此外,在本研究中,我们证明在分泌晚期蜕膜化的基质中,与分泌中期基质细胞相比,MMEP-IR显著降低。MMEP-IR的这些变化与以下可能性一致,即同样在子宫内膜中产生的内皮素在经前期免受失活作用,并可能作用于螺旋小动脉。这些发现支持了MMEP在影响子宫内膜血管稳态的旁分泌相互作用中的作用。